Birmingham, AL, United States of America

Lawrence S Lamb

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Lawrence S. Lamb

Introduction

Lawrence S. Lamb is a notable inventor based in Birmingham, AL (US), recognized for his significant contributions to the field of cancer treatment. With a total of 5 patents, he has made strides in developing innovative therapies that combine chemotherapy and immunotherapy.

Latest Patents

Among his latest patents, one focuses on drug-resistant immunotherapy for the treatment of cancer. This patent discloses methods for combining chemotherapy and immunotherapy, aiming to generate a drug-resistant cytotoxic immune cell line for use alongside cytotoxic drugs. Another significant patent involves genetically engineered drug-resistant T cells, providing novel cell compositions that express a chimeric antigen receptor and a survival factor, along with methods for their application.

Career Highlights

Lawrence has worked with esteemed organizations such as the UAB Research Foundation and Emory University, where he has contributed to groundbreaking research and development in cancer therapies. His work has been pivotal in advancing the understanding and treatment of cancer through innovative approaches.

Collaborations

Throughout his career, Lawrence has collaborated with notable colleagues, including Harold Trent Spencer and Anindya Dasgupta, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Lawrence S. Lamb's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His contributions continue to influence the field and offer hope for improved cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…